MRI biomarkers in neuro-oncology

M Smits - Nature Reviews Neurology, 2021 - nature.com
… of imaging biomarkers, which requires quantitative image acquisition and analysis, now
offers the opportunity to move precision diagnostics forward. Both imaging biomarkers and …

[HTML][HTML] Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives

FY Chiu, Y Yen - Biomarker Research, 2023 - Springer
Diagnostic biomarkers are the key elements to diagnose a disease or a pathogenic process
through monitoring situations. It not only serves as a predictive or prognostic marker to …

Quantitative imaging biomarkers in neuro-oncology

AD Waldman, A Jackson, SJ Price, CA Clark… - … Clinical Oncology, 2009 - nature.com
… of reliable, noninvasive, quantitative biomarkers for tumor characterization and prognosis,
and … This Review summarizes the current state of quantitative imaging in neuro-oncology, by …

Artificial intelligence for radiomics; diagnostic biomarkers for neuro-oncology

F Vahedifard, S Hassani, A Afrasiabi… - World Journal of Advanced …, 2022 - wjarr.com
… New biomarkers for old diseases Numerous diagnostic biomarkers can be used to detect …
We can apply ancient pathological biomarkers in novel diagnostic criteria, which is intriguing. …

The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology

DN Cagney, J Sul, RY Huang, KL Ligon… - … -oncology, 2018 - academic.oup.com
… A diagnostic biomarker is used to identify individuals with a disease or condition or to define
a subset of the disease. Diagnostic biomarkers are frequently used in neuropathology and …

Recent developments in blood biomarkers in neuro-oncology

JB Foster, MP Koptyra, SJ Bagley - … Neurology and Neuroscience Reports, 2023 - Springer
… While ctDNA proved to be both identifiable and informative in this study, it was not sufficient
to diagnose CNS lymphoma without a biopsy. Mutter et al. designed an algorithm to identify …

AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium

C Davatzikos, JS Barnholtz-Sloan, S Bakas… - … -oncology, 2020 - academic.oup.com
… Artificial intelligence (AI) and machine learning (ML) methods have begun to reveal that
complex imaging patterns can provide individualized biomarkers for diagnosis and prognosis. …

Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application

N Mikolajewicz, PP Yee, D Bhanja, M Trifoi… - … of Clinical Oncology, 2024 - ascopubs.org
… These data support CD14 as a diagnostic biomarker of … biomarker, we expect that the
forthcoming years in neuro-oncologic CSF research will fulfill the need for noninvasive diagnostics

[HTML][HTML] How nanotechnology and biomedical engineering are supporting the identification of predictive biomarkers in neuro-oncology

M Ganau, M Paris, N Syrmos, L Ganau, GKI Ligarotti… - Medicines, 2018 - mdpi.com
… in the Biomarkers, … biomarkers according to their specific role into the following more
homogeneous groups: susceptibility risk biomarkers, diagnostic biomarkers, monitoring biomarkers

Molecular biomarker testing for the diagnosis of diffuse gliomas: guideline from the College of American Pathologists in collaboration with the American Association of …

DJ Brat, K Aldape, JA Bridge… - … of pathology & …, 2022 - meridian.allenpress.com
Context.— The diagnosis and clinical management of patients with diffuse gliomas (DGs)
have evolved rapidly over the past decade with the emergence of molecular biomarkers that …